Dr. Shi Yuankai

Hospital

National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

Experience

30+ years in medical oncology

Languages

English, Mandarin

About

Vice President; Chief Physician; Professor

Specialties

Medical oncologylung cancer chemotherapy and immunotherapylymphomaclinical trials design

Background

Led numerous Phase III clinical trials introducing novel immunotherapy agents (PD-1/PD-L1 inhibitors) in China; key contributor to Chinese clinical guidelines for lung cancer and lymphoma treatment; published in New England Journal of Medicine, The Lancet; instrumental in bringing multiple oncology drugs to Chinese market approval

For International Patients

An excellent choice for patients seeking access to the latest immunotherapy clinical trials or second opinions on advanced lung cancer treatment plans.

Verify Credentials

Research this doctor's background on trusted platforms.

Google ScholarSearch PubMedSearch

Results are automated searches and may include other individuals with similar names.

Information is provided for reference only and may not reflect current conditions. Please verify directly with the hospital before making decisions.